Cholesterol biosynthesis inhibition synergizes with AKT inhibitors in triple-negative breast cancer

Alissandra L. Hillis(Beth Israel Deaconess Medical Center), Alex Toker(Beth Israel Deaconess Medical Center)
bioRxiv (Cold Spring Harbor Laboratory)
January 16, 2024
10.1101/2024.01.16.575899
Cited by 0

Related Papers

Signalling through the lipid products of phosphoinositide-3-OH kinase
|Nature|1997|1.3k
Sequence analysis of mutations and translocations across breast cancer subtypes
|Nature|2012|1.2k
Signaling through protein kinase C
|Frontiers in bioscience|1998|324
A Phosphorylation State-specific Antibody Recognizes Hsp27, a Novel Substrate of Protein Kinase D
|Journal of Biological Chemistry|2005|162
Targeting Akt3 Signaling in Triple-Negative Breast Cancer
|Cancer Research|2013|155